1.How does one differentiate between serotonin syndrome, neuroleptic malignant syndrome and malignant hyperthermia?
2.2. KO is a 15 yo receiving valproic acid. What are the indications for this medication and what are the monitoring parameters?

  1. KP is a 24 that is receiving dexmethphenidate for ADHD. What are the monitoring parameters for efficacy and toxicity?
  2. LK is a 34 yo receiving fentanyl IV. The nurse anesthetist notices he is becoming difficult to ventilate and has chest wall rigidity. Please explain this side effect to IV fentanyl?
  3. Mk is a 65 yo with a DVT in the right leg. To be started on warfarin. Currently on heparin? Why is it suggested that there be a 3-5 day overlap of the two meds despite the INR being therapeutic after 2 days?
  4. TY is an NP student. He is learning about warfarin. DO all disease states that require warfarin (stroke prevention, DVT treatment, post cardiac stent insertion) all require the same INR? Please explain.
  5. FT has a history of afib. He saw a commercial for apixaban and wants to know if he can use that vs warfarin. What is this med and what are its indications for it.
    Note; this a pharmacology class, pls go straight to the point. References should be current.

Sample Solution

This question has been answered.

Get Answer